Matches in SemOpenAlex for { <https://semopenalex.org/work/W2747787806> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2747787806 abstract "Abstract Mental disorders are one of the leading causes of disability globally. Inherited genetic variation in pharmacokinetic (PK) and pharmacodynamic (PD) genes may contribute to the observed interindividual differences in clinical efficacy and tolerability of psychopharmaceuticals. Therefore, strategies for improving effectiveness of pharmacological treatments translating pharmacogenomic information from bench to clinic have been recently attempted. However, effectiveness of available psychiatric pharmacogenomic tools in ameliorating clinical symptoms has not been analyzed in populations of suitable size by means of adequately powered multicentric randomized clinical trials. The Neuropharmagen personalized medicine platform integrates pharmacogenomic data from the analysis of PK and PD genes to provide actionable recommendations for psychoactive drugs, including genotype-specific dose adjustments and the risk of specific adverse effects based on FDA-approved drug labelling, Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines, and meta-analyses of clinical studies. Moreover, within the Neuropharmagen platform, pharmacogenomic recommendations can be complemented combined with alerts on drug-drug, drug-clinical condition and drug-environmental factor interactions. Notably, the later can be updated by the doctor whenever there are changes in the condition of the patient or the pharmacological treatment. Clinical efficacy of the Neuropharmagen test has been evaluated in two multicentric clinical studies totaling 462 patients analyzed for the primary outcome at study endpoint. A retrospective study evaluating patients with different psychiatric diagnoses and at least 1 treatment failure found that patients whose treatment followed the pharmacogenetic (PGx) test recommendations had odds of improvement about 4 times higher than patients whose treatment did not (adjusted OR = 3.86, 95%CI 1.36–10.95; p = 0.011). Recently, we have completed a prospective randomized clinical trial conducted in 316 patients with major depressive disorder with a wide range of depression severities and number of treatment failures. In this talk, I will describe the main results of both studies, with a major focus in those obtained in the multicentric randomized clinical trial. Overall, the combined results of studies conducted with Neuropharmagen show that PGx-guided treatment constitutes a significant tool to improve clinical response and medication tolerability, especially in subjects with moderate to severe depression and in those with previous failed drug trials." @default.
- W2747787806 created "2017-08-31" @default.
- W2747787806 creator A5019533016 @default.
- W2747787806 creator A5044431149 @default.
- W2747787806 creator A5045146612 @default.
- W2747787806 creator A5051648227 @default.
- W2747787806 creator A5060448553 @default.
- W2747787806 creator A5061926369 @default.
- W2747787806 creator A5083202579 @default.
- W2747787806 creator A5086084955 @default.
- W2747787806 creator A5087947173 @default.
- W2747787806 date "2017-01-01" @default.
- W2747787806 modified "2023-10-18" @default.
- W2747787806 title "Pharmacogenomic Information In The Treatment Of Major Depression: Results From A Randomized Clinical Trial" @default.
- W2747787806 doi "https://doi.org/10.1016/j.euroneuro.2016.09.388" @default.
- W2747787806 hasPublicationYear "2017" @default.
- W2747787806 type Work @default.
- W2747787806 sameAs 2747787806 @default.
- W2747787806 citedByCount "0" @default.
- W2747787806 crossrefType "journal-article" @default.
- W2747787806 hasAuthorship W2747787806A5019533016 @default.
- W2747787806 hasAuthorship W2747787806A5044431149 @default.
- W2747787806 hasAuthorship W2747787806A5045146612 @default.
- W2747787806 hasAuthorship W2747787806A5051648227 @default.
- W2747787806 hasAuthorship W2747787806A5060448553 @default.
- W2747787806 hasAuthorship W2747787806A5061926369 @default.
- W2747787806 hasAuthorship W2747787806A5083202579 @default.
- W2747787806 hasAuthorship W2747787806A5086084955 @default.
- W2747787806 hasAuthorship W2747787806A5087947173 @default.
- W2747787806 hasConcept C104317684 @default.
- W2747787806 hasConcept C126322002 @default.
- W2747787806 hasConcept C135763542 @default.
- W2747787806 hasConcept C168563851 @default.
- W2747787806 hasConcept C170734499 @default.
- W2747787806 hasConcept C177713679 @default.
- W2747787806 hasConcept C185592680 @default.
- W2747787806 hasConcept C197934379 @default.
- W2747787806 hasConcept C203092338 @default.
- W2747787806 hasConcept C2778375690 @default.
- W2747787806 hasConcept C2780035454 @default.
- W2747787806 hasConcept C32220436 @default.
- W2747787806 hasConcept C535046627 @default.
- W2747787806 hasConcept C55493867 @default.
- W2747787806 hasConcept C55775858 @default.
- W2747787806 hasConcept C60644358 @default.
- W2747787806 hasConcept C71924100 @default.
- W2747787806 hasConcept C86803240 @default.
- W2747787806 hasConcept C98274493 @default.
- W2747787806 hasConceptScore W2747787806C104317684 @default.
- W2747787806 hasConceptScore W2747787806C126322002 @default.
- W2747787806 hasConceptScore W2747787806C135763542 @default.
- W2747787806 hasConceptScore W2747787806C168563851 @default.
- W2747787806 hasConceptScore W2747787806C170734499 @default.
- W2747787806 hasConceptScore W2747787806C177713679 @default.
- W2747787806 hasConceptScore W2747787806C185592680 @default.
- W2747787806 hasConceptScore W2747787806C197934379 @default.
- W2747787806 hasConceptScore W2747787806C203092338 @default.
- W2747787806 hasConceptScore W2747787806C2778375690 @default.
- W2747787806 hasConceptScore W2747787806C2780035454 @default.
- W2747787806 hasConceptScore W2747787806C32220436 @default.
- W2747787806 hasConceptScore W2747787806C535046627 @default.
- W2747787806 hasConceptScore W2747787806C55493867 @default.
- W2747787806 hasConceptScore W2747787806C55775858 @default.
- W2747787806 hasConceptScore W2747787806C60644358 @default.
- W2747787806 hasConceptScore W2747787806C71924100 @default.
- W2747787806 hasConceptScore W2747787806C86803240 @default.
- W2747787806 hasConceptScore W2747787806C98274493 @default.
- W2747787806 hasLocation W27477878061 @default.
- W2747787806 hasOpenAccess W2747787806 @default.
- W2747787806 hasPrimaryLocation W27477878061 @default.
- W2747787806 hasRelatedWork W1243096322 @default.
- W2747787806 hasRelatedWork W1480207804 @default.
- W2747787806 hasRelatedWork W2124981826 @default.
- W2747787806 hasRelatedWork W2138062078 @default.
- W2747787806 hasRelatedWork W2321715189 @default.
- W2747787806 hasRelatedWork W2398524292 @default.
- W2747787806 hasRelatedWork W2557148745 @default.
- W2747787806 hasRelatedWork W2561767244 @default.
- W2747787806 hasRelatedWork W2624014376 @default.
- W2747787806 hasRelatedWork W2756135123 @default.
- W2747787806 hasRelatedWork W2790533145 @default.
- W2747787806 hasRelatedWork W2803487239 @default.
- W2747787806 hasRelatedWork W2886309064 @default.
- W2747787806 hasRelatedWork W2904708914 @default.
- W2747787806 hasRelatedWork W2911237729 @default.
- W2747787806 hasRelatedWork W2971997978 @default.
- W2747787806 hasRelatedWork W3035632137 @default.
- W2747787806 hasRelatedWork W3160459154 @default.
- W2747787806 hasRelatedWork W3186638888 @default.
- W2747787806 hasRelatedWork W3126684199 @default.
- W2747787806 isParatext "false" @default.
- W2747787806 isRetracted "false" @default.
- W2747787806 magId "2747787806" @default.
- W2747787806 workType "article" @default.